EPN Stock: price and insider trades · Australia

Every trade that managers of EPN disclose to ASX is tracked on this page. The company sits in the Health Care sector. The last twelve months, up to 18 October 2026, brought 4 filings signed by 3 insiders.

Not one open-market sale was filed. On the buying side, 2 insiders reported 3 purchases totalling €15k. The totals exclude 2 filings filed without an amount. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The buyers include 2 senior executives. Alan Preston Beasley filed the largest purchase, €15k, on 11 May 2026, which represents 0.25% of the company's market value.

The last purchase on record was published on 8 June 2026, which is 131 days ago.

With 4 filings in twelve months, the company is more active than the median of 3 filings across the 2,530 companies we follow on the same exchange. Our records for EPN go back to 2026, with 3 purchases and no sales on the open market in total.

In the same sector, recent insider purchases at Cooper Companies, Inc. and Cytosorbents Corp also feature in our signals. This summary is built from ASX disclosures alone and does not predict where the share price will go.